Sign In
Buy ABT
$100.79
+0.200 (+0.199%)
At Close: Jul 23, 2026
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
07:01am, Wednesday, 27'th May 2026
Cologuard® and Cologuard Plus® reaffirmed as preferred options for noninvasive colorectal cancer (CRC) screening in updated American Cancer Society guideline Abbott to offer only CRC screening portf
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
09:00am, Tuesday, 26'th May 2026
Data highlight how screening and diagnostics enable earlier detection, more precise treatment decisions, and improved patient outcomes from risk to remission New MRD data from the PARTNER study demons
The Smartest Growth Stocks to Invest $10,000 in As Investors Rotate Out of Tech
09:15pm, Friday, 22'nd May 2026
When investors take a risk-off attitude, stocks with attractive, growing dividends are often their safe-haven option.
3 Stocks to Buy if You Think the Economy Is Heading for a Recession
02:30am, Thursday, 21'st May 2026
They have increased their payouts for a combined 171 years straight.
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
09:41am, Wednesday, 20'th May 2026
ABT's EPD unit posts 9% Q1 sales growth as biosimilars and emerging market demand support its long-term expansion plans.
Silver Economy Investing: Why the Healthcare Giants Are in Focus
04:01pm, Tuesday, 19'th May 2026
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
The Dip That Keeps On Dipping: 2 Strong Buy Stocks Near 52-Week Lows With 50%+ Upside Potential
07:30am, Tuesday, 19'th May 2026
Build-A-Bear Workshop and Abbott Laboratories are compelling dividend stocks, each trading near lows with yields close to 3%. BBW offers a debt-free balance sheet, aggressive share repurchases, and in
Boston Scientific Bets on Growth Through Strategic M&A Deals
03:17pm, Monday, 18'th May 2026
BSX expands into fast-growing medtech segments with acquisitions spanning urology, pain management and vascular devices.
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
10:16am, Monday, 18'th May 2026
Abbott vs. Zimmer Biomet: surgical equipment stocks face diverging growth, acquisitions, and valuation shifts as investors weigh momentum and margins.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 18'th May 2026
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
How Abbott's Volume-Driven Nutrition Strategy Is Shaping Up
11:16am, Friday, 15'th May 2026
ABT shifts to a volume-led Nutrition strategy with pricing moves and new product launches after Q1 sales declined 6%.
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Tuesday, 12'th May 2026
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Abbott: Three Supercycles, Mispriced At A 10-Year Low
10:02am, Monday, 11'th May 2026
Abbott Laboratories trades at a decade low of 17.7x forward earnings despite 13.2% Q1 2026 Medical Devices growth and a 54-year dividend streak. Three underappreciated catalysts—Exact Sciences syner
Abbott Laboratories Is On Sale, Don't Overlook It
08:00am, Saturday, 09'th May 2026
Abbott Laboratories is trading at a 27% discount to fair value, offering a compelling entry point for long-term investors. ABT's Medical Devices and Diagnostics segments drive robust growth, with the
Abbott's Medical Device Strategy Supports Long-Term Growth Outlook
09:40am, Friday, 08'th May 2026
ABT's Medical Devices segment posts 8.5% Q1 growth as Electrophysiology, Rhythm Management and Heart Failure deliver strong gains.
